Company Filing History:
Years Active: 2018
Title: Ingrid Berger: Innovator in Pharmaceutical Treatments
Introduction
Ingrid Berger is a notable inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory and autoimmune diseases. Her innovative approach has led to the development of a unique method that has the potential to improve patient outcomes.
Latest Patents
Ingrid Berger holds a patent for a method for treating an inflammatory disease and/or an autoimmune disease with a soluble FcγRIIb. The invention involves providing a pharmaceutical composition containing a therapeutically effective amount of soluble FcγR, which is administered to a patient. This method includes a safety period followed by a treatment cycle of at least two weekly administrations. The composition is designed to effectively treat or prevent these diseases in patients.
Career Highlights
Ingrid is associated with Suppremol GmbH, where she has been instrumental in advancing research and development in her field. Her work has garnered attention for its innovative approach to complex medical conditions.
Collaborations
Ingrid collaborates with esteemed colleagues, including Peter Buckel and Peter Sondermann, who contribute to her research efforts and the development of her patented methods.
Conclusion
Ingrid Berger's contributions to pharmaceutical innovations highlight her dedication to improving healthcare through scientific advancements. Her work exemplifies the impact of innovative thinking in addressing critical medical challenges.